Literature DB >> 9603930

A kinetic analysis of the oligonucleotide-modulated ATPase activity of the helicase domain of the NS3 protein from hepatitis C virus. The first cycle of interaction of ATP with the enzyme is unique.

D J Porter1.   

Abstract

Hepatitis C virus (HCV) helicase (E) formed spectrofluorometrically detectable complexes with a 16-mer and HF16 (a 16-mer with 5'-hexachlorofluoresceinyl moiety). The interaction of helicase with these effectors was investigated by kinetic techniques to determine if the complexes were kinetically competent for ATP hydrolysis. kcat values with the 16-mer and HF16 were 2.7 and 36 s-1, respectively. The maximal value of the rate constant for the approach of an intermediate to the steady-state level has to be at least 4-fold greater than kcat for it to be kinetically competent. This value was 1.2 s-1 with HF16 and "E.ATP" and was 1.82 s-1 with ATP and E.HF16. These values were too small for formation of these intermediates to be kinetically competent in ATP hydrolysis. Dissociation of "E.HF16. ATP" (0.34 s-1) was also too slow to contribute significantly to catalysis. Furthermore, the Km of E.HF16 for ATP (3 mircoM) was significantly less than the Km for ATP hydrolysis at a saturating concentration of HF16 (320 microM). HCV helicase has two nucleotide-binding sites per monomer. If the fluorescence changes observed were associated with structure changes preceding steady-state catalysis (isomerization), pre-steady-state data could be reconciled with the turnover data. Data for the 16-mer yielded similar conclusions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603930     DOI: 10.1074/jbc.273.23.14247

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

2.  Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme.

Authors:  P Borowski; A Niebuhr; O Mueller; M Bretner; K Felczak; T Kulikowski; H Schmitz
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase.

Authors:  Vaishnavi Rajagopal; Madhura Gurjar; Mikhail K Levin; Smita S Patel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

4.  Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA.

Authors:  R Banerjee; A Dasgupta
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Role of single-stranded DNA binding activity of T antigen in simian virus 40 DNA replication.

Authors:  C Wu; R Roy; D T Simmons
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Roles of the AX(4)GKS and arginine-rich motifs of hepatitis C virus RNA helicase in ATP- and viral RNA-binding activity.

Authors:  S C Chang; J C Cheng; Y H Kou; C H Kao; C H Chiu; H Y Wu; M F Chang
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Structure-based mutagenesis study of hepatitis C virus NS3 helicase.

Authors:  C Lin; J L Kim
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Localisation of the human hSuv3p helicase in the mitochondrial matrix and its preferential unwinding of dsDNA.

Authors:  Michal Minczuk; Jan Piwowarski; Monika A Papworth; Karen Awiszus; Sarah Schalinski; Andrzej Dziembowski; Aleksandra Dmochowska; Ewa Bartnik; Kostas Tokatlidis; Piotr P Stepien; Peter Borowski
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 9.  The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

Authors:  David N Frick
Journal:  Curr Issues Mol Biol       Date:  2007-01       Impact factor: 2.081

10.  Steady-state NTPase activity of Dengue virus NS3: number of catalytic sites, nucleotide specificity and activation by ssRNA.

Authors:  J Jeremías Incicco; Leopoldo G Gebhard; Rodolfo M González-Lebrero; Andrea V Gamarnik; Sergio B Kaufman
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.